AMRN (Amarin Corp Plc) Stock Analysis - Analyst Ratings

Amarin Corp Plc (AMRN) is a publicly traded Healthcare sector company. As of May 21, 2026, AMRN trades at $13.58 with a market cap of $294.83M and a P/E ratio of -177.50. AMRN moved +1.92% today. Year to date, AMRN is +5.70%; over the trailing twelve months it is +28.44%. Its 52-week range spans $7.08 to $20.90. Analyst consensus is sell with an average price target of $12.00. Rallies surfaces AMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate AMRN?

1 analysts cover AMRN: 0 strong buy, 0 buy, 0 hold, 1 sell, and 0 strong sell. The consensus rating is sell. The average price target is $12.00.

AMRN Key Metrics

Key financial metrics for AMRN
MetricValue
Price$13.58
Market Cap$294.83M
P/E Ratio-177.50
EPS$-0.08
Dividend Yield0.00%
52-Week High$20.90
52-Week Low$7.08
Volume14
Avg Volume0
Revenue (TTM)$216.76M
Net Income$-33.61M
Gross Margin52.37%

AMRN Analyst Consensus

1 analysts cover AMRN: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $12.00.

Latest AMRN News

Recent AMRN Insider Trades

  • Berg Aaron bought 160.00K (~$102.40K) on Aug 2, 2024.

Common questions about AMRN

What do analysts rate AMRN?
1 analysts cover AMRN: 0 strong buy, 0 buy, 0 hold, 1 sell, and 0 strong sell. The consensus rating is sell. The average price target is $12.00.
Does Rallies show AMRN price targets?
Yes. Rallies tracks AMRN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is AMRN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AMRN. It does not provide personalized investment advice.
AMRN

AMRN